Evidence map›Paper›PMID 16724230›Full record

ArticleDiabetologia2006

Association of sequence variations in the gene encoding adiponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish Diabetes Prevention Study.

N Siitonen, L Pulkkinen, U Mager, J Lindström, J G Eriksson, T T Valle, H Hämäläinen, P Ilanne-Parikka, S Keinänen-Kiukaanniemi, J Tuomilehto and 2 more

Registry-linked trialOpen access · bronzeAbstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Diabetologia, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00518167 (The Finnish Diabetes Prevention Study), which is not on this map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00518167 naunknown statusnot on this map

The Finnish Diabetes Prevention Study: A Follow-up Study on the Effect of a Dietary and Exercise Intervention in the Prevention of Diabetes and Its Vascular Complications

TypeinterventionalSponsorFinnish Institute for Health and WelfareRan1993 to 2023Enrolled522ConditionsType 2 DiabetesArmsIntensive lifestyle counselling
3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Polymorphism in Adiponectin and Adiponectin Receptor Genes in Diabetes Mellitus Pathogenesis.Pathophysiology : the official journal of the International Society for Pathophysiology · 2022
    Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Non-coding functions of alternative pre-mRNA splicing in development.Seminars in cell & developmental biology · 2015
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

N SiitonenDepartment of Public Health and Clinical Nutrition, Clinical Nutrition, and Food and Health Research Centre, University of Kuopio, Kuopio, Finland.
L Pulkkinen
U Mager
J Lindström
J G Eriksson
T T Valle
H Hämäläinen
P Ilanne-Parikka
S Keinänen-Kiukaanniemi
J Tuomilehto
M Laakso
M Uusitupa
University of Eastern Finland · FIFinnish Diabetes Association · FISocial Insurance Institution · FIUniversity of Helsinki · FIUniversity of Oulu · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aims/hypothesisAdiponectin is a circulating peptide derived from adipose tissue. It mediates its insulin-sensitising and anti-atherogenic effects on target tissues through two known receptors, adiponectin receptors 1 and 2 (ADIPOR1; ADIPOR2), which are encoded by the genes ADIPOR1 and ADIPOR2. Our aim was to study the association of ADIPOR1 gene variations with body size and risk of type 2 diabetes in subjects with impaired glucose tolerance, who participated in the Finnish Diabetes Prevention Study (DPS). SUBJECTS AND

methodsWe selected seven single nucleotide polymorphisms (SNPs) of the ADIPOR1 gene to perform association studies with anthropometrics and metabolic parameters at baseline, and with the risk of type 2 diabetes during the 3-year follow-up in the DPS study population. Both single SNP analysis and haplotype effects were studied.

resultsThree out of seven markers studied (rs10920534, rs22757538 and rs1342387) were significantly associated with various body size measurements including weight, height, waist and hip circumference, sagittal diameter and body mass index. Furthermore, three markers (rs10920534, rs12045862 and rs7539542), of which two were different from those associating with body size, were linked to fasting and 2-h insulin levels, particularly in men at baseline. The haplotype analysis with five markers revealed seven major haplotypes in the DPS study population. The haplotype effects on body size measures were in line with those of single SNP analysis. However, none of the markers were associated with the risk of type 2 diabetes. CONCLUSIONS/

interpretationOur findings suggest that ADIPOR1 has a putative role in the development of body size, and that traits for central adiposity and insulin resistance may be dissociated from each other.

Indexed as

Genetic VariationPolymorphism, Single NucleotideBody SizeChromosome MappingCodonDiabetes MellitusExonsFemaleFinlandGenetic MarkersHumansInsulinInsulin ResistanceLinkage DisequilibriumMaleMiddle AgedADIPOR1 protein, humanADIPOR2 protein, humanCodonGenetic MarkersInsulinReceptors, AdiponectinReceptors, Cell Surface

Identifiers

PMID16724230
OpenAlexW1971045460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.